Growth Metrics

West Pharmaceutical Services (WST) Interest & Investment Income (2009 - 2026)

West Pharmaceutical Services recorded quarterly Interest & Investment Income of $5.1 million in Q1 2026, little changed quarter-over-quarter from $5.1 million in Q4 2025, and up 24.39% year-over-year from $4.1 million in Q1 2025.

West Pharmaceutical Services' Interest & Investment Income history runs 18 years deep, the most recent figure standing at $5.1 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income rose 24.39% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $18.5 million (up 5.71% YoY), while the FY2025 annual figure was $17.5 million, down 10.71% from the prior year.
  • Interest & Investment Income came in at $5.1 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $5.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $9.4 million in Q4 2023 to a low of $300000.0 in Q1 2022.
  • A 5-year average of $4.4 million and a median of $4.7 million in 2025 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income surged 1500.0% in 2023 and plunged 48.94% in 2024, its largest moves.
  • West Pharmaceutical Services' Interest & Investment Income stood at $2.9 million in 2022, then surged by 224.14% to $9.4 million in 2023, then slumped by 48.94% to $4.8 million in 2024, then gained by 6.25% to $5.1 million in 2025, then changed by 0.0% to $5.1 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $5.1 million, $5.1 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 9.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 12.29 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.10 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -62.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 3.91 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -66.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 3.64 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 6.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.10 Mn
Dec 31, 2025 5.10 Mn
Sep 30, 2025 4.70 Mn
Jun 30, 2025 3.60 Mn
Mar 31, 2025 4.10 Mn
Dec 31, 2024 4.80 Mn
Sep 30, 2024 4.60 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 6.20 Mn
Dec 31, 2023 9.40 Mn
Sep 30, 2023 8.80 Mn
Jun 30, 2023 5.00 Mn
Mar 31, 2023 4.80 Mn
Dec 31, 2022 2.90 Mn
Sep 30, 2022 1.50 Mn
Jun 30, 2022 400,000.00
Mar 31, 2022 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 400,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 100,000.00
Dec 31, 2020 200,000.00
Sep 30, 2020 200,000.00
Jun 30, 2020 200,000.00
Mar 31, 2020 800,000.00
Dec 31, 2019 1.30 Mn
Sep 30, 2019 1.00 Mn
Jun 30, 2019 600,000.00
Mar 31, 2019 900,000.00
Dec 31, 2018 700,000.00
Sep 30, 2018 500,000.00
Jun 30, 2018 300,000.00
Mar 31, 2018 600,000.00
Dec 31, 2017 400,000.00
Sep 30, 2017 300,000.00
Jun 30, 2017 300,000.00
Mar 31, 2017 300,000.00
Dec 31, 2016 300,000.00
Sep 30, 2016 200,000.00
Jun 30, 2016 300,000.00
Mar 31, 2016 300,000.00
Dec 31, 2015 300,000.00
Sep 30, 2015 500,000.00
Jun 30, 2015 400,000.00
Mar 31, 2015 400,000.00
Dec 31, 2014 800,000.00
Sep 30, 2014 1.80 Mn
Jun 30, 2014 500,000.00
Mar 31, 2014 400,000.00
Dec 31, 2013 500,000.00
Sep 30, 2013 400,000.00
Jun 30, 2013 400,000.00
Mar 31, 2013 600,000.00
Dec 31, 2012 300,000.00
Sep 30, 2012 500,000.00
Jun 30, 2012 600,000.00
Mar 31, 2012 400,000.00
Dec 31, 2011 400,000.00
Sep 30, 2011 400,000.00
Jun 30, 2011 300,000.00
Mar 31, 2011 200,000.00
Dec 31, 2010 300,000.00
Sep 30, 2010 100,000.00
Jun 30, 2010 100,000.00
Mar 31, 2010 100,000.00
Dec 31, 2009 200,000.00
Sep 30, 2009 300,000.00
Jun 30, 2009 100,000.00